Over 90 percent of breast cancer cases are diagnosed during the earlier stages of the disease. Early spotting is beneficial for the patient as it typically means better treatment and a stronger prognosis.
Nonetheless, early diagnosis is only a fraction of the whole medical picture. Other disease characteristics, like hormone receptors and lymph nodes, can aid in prognosis results and help doctors and patients choose the right treatment.
Though breast cancer rates are increasing in North America and the United Kingdom, the fatality rate is falling. This declining death rate is accredited to more women getting mammograms, better evaluation processes, and more potent secondary treatments.
Thus if the majority of diagnosed breast cancer cases are discovered during the preliminary stages, what effect does that have on patients and what are the best treatment courses?
An Overview of the Earlier Symptoms of this Disease
Earlier breast cancer stages are called TNM stages 1, 2 and 3a. This scoring system approximates how far the carcinoma has advanced. It's also based on whether any present tumors are operable.
The majority of early breast cancer cases are cured through either surgery, radiation therapy, systemic therapy or a combination of the three, resulting in a much greater survival rate.
Normal Treatment Reactions
Treatment reaction generally hinges on lymph node engagement, the size and grade of any tumors, the age of the patient, hormone (estrogen and progesterone) receptors, and the status or condition of biologic markers like HER2/neu.
Lymph Node Indicators
Lymph nodes are an effective way to predict the effects of breast cancer. Essentially, the more positive lymph nodes that are present, the lower the patient's survival rate and the higher the chances of relapse.
Typically, patients with early stage breast cancer are grouped into either those having negative nodes, 1 to 3 positive ones, 4 to 9, or 10 and higher.
The Size of Tumor
Tumor size is another indicator and can be especially useful for patients with negative lymph nodes. Essentially, if a patient has negative nodes and a tumor that is less than 1cm, the prognosis is very favorable.
The Grade of Tumor
As the grade of the tumor increases, so does the potential relapse rate. However, due to the unreliability of tumor data, most pathologists do not rely on this information for their prognosis.
Estrogen and Progesterone Receptors
The status of hormone receptors in the tumor is another indicator used by doctors when prognosing early stage breast cancer. Typically, patients who experience a receptor-positive cancer have a stronger survival rate than those who do not.
HER2/neu
HER2/neu is what's called a marker - it's a biological element typically present in the body or within the tumor in about 25% of all breast cancer cases. When HER2/neu levels are high, that usually translates to a more aggressive variety of breast cancer and a worse prognosis.
Age of the Patient
Generally, patients who are older (50 and up) have a better prognosis than patients under the age of 35.
For helpful information on various cancers - please visit cancerinfotips.com - a popular site providing symptom and treatment insights - such as ovarian cancer warning signs - Neuroblastoma stage 4 - and many more!
No comments:
Post a Comment